Mazdutide vs Survodutide: The GLP-1/Glucagon Dual Agonists Compared
Mazdutide vs survodutide: two GLP-1/glucagon dual agonists compared, from oxyntomodulin origins to GLORY-1 and SYNCHRONIZE results, liver data, and sourcing in Canada.
Archive
Category: Metabolic Research
Incretin and metabolic research explained: GLP-1, GIP and glucagon receptor agonists, amylin analogues, AMPK, brown adipose tissue and compounds such as AOD-9604 and 5-Amino-1MQ, with their status in Canada.
Cagrilintide: The Amylin Analogue Behind CagriSema, Explained
Cagrilintide explained: the long-acting amylin analogue in CagriSema, what its phase 2 and REDEFINE trials found, its Calgary connection, and sourcing in Canada.
AOD-9604: What the Research Shows
AOD-9604 explained: the Monash-designed growth hormone fragment, why its obesity trials failed, what's still studied, and sourcing in Canada.